Skip to main content
Clinical Trials/NCT04624802
NCT04624802
Unknown
Not Applicable

The Effect of Maternal Exercise on Anxiety During Normal Pregnancy:a Randomized Controlled Trial

Shenzhen Second People's Hospital0 sites220 target enrollmentNovember 10, 2020
ConditionsAnxiety

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
Shenzhen Second People's Hospital
Enrollment
220
Primary Endpoint
Change from Baseline of State Anxiety at 32 Weeks of Gestation
Last Updated
5 years ago

Overview

Brief Summary

This is a randomized controlled trial study. We evaluate effectiveness of maternal exercise on anxiety during normal pregnancy compared to those who receive antenatal care regularly. We plan to recruit 220 healthy pregnant women over the age of 18 in Shenzhen and to use a standard maternal exercise from Korea as intervention.

Registry
clinicaltrials.gov
Start Date
November 10, 2020
End Date
August 1, 2023
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Shenzhen Second People's Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant women who are over 18 years old and confirmed to be pregnant in Shenzhen Dapeng New District.

Exclusion Criteria

  • 1.pregnant women who have accepted maternal exercise training (at least twice a week in last month);2.pregnant women who have orthopedics, cardiovascular or mental diseases; 3.pregnant women who have or had any condition as follows:miscarriage more than two times,premature delivery,placenta previa,fetal dysplasia, low weight before pregnancy (BMI \<17.5),polycyesis,preeclampsia,premature rupture of membranes,Uterine growth retardation,cervical/ligation,repeated vaginal bleeding,anemia or diabetes; 4.the gestational age is less than 12 weeks or more than 16 weeks;5.received psychotherapy or psychotropic medication within 6 months before the study;6.can not participate in regular inspections.

Outcomes

Primary Outcomes

Change from Baseline of State Anxiety at 32 Weeks of Gestation

Time Frame: The participants are examined between 12 and 16 weeks of gestation (baseline visit) and at gestation week 32 (after the intervention).

We use state anxiety subscale of State-Trait Anxiety Inventory (STAI) as the measure of anxiety severity. The STAI comprises two-self report scales for measuring two distinct anxiety concepts, the State anxiety and Trait anxiety. Both scales contain 20 statements that ask the respondent to describe how she feels at a particular moment (state anxiety) or how she generally feels (trait anxiety). State anxiety is conceptualized as a transitory emotional state, where as trait anxiety refers to relatively stable individual differences in proneness to anxiety. The respondents are required to rate themselves on a four point likert scale 'not at all' to 'very much so on' various anxiety related symptoms which they experience in the past weeks for the state scale or how they generally feel for the trait scale. STAI is widely used and has been shown to have high reliability and validity with a Cronbach's alpha of 0.88 and 0.83 for state (STAI-I) and trait anxiety (STAI-II) respectively.

Secondary Outcomes

  • Change from Baseline of Pain at 32 Weeks of Gestation(The participants are examined between 12 and 16 weeks of gestation (baseline visit) and at gestation week 32 (after the intervention).)
  • Change from Baseline of Depressive Symptom at 32 Weeks of Gestation(The participants are examined between 12 and 16 weeks of gestation (baseline visit) and at gestation week 32 (after the intervention).)

Similar Trials